149 related articles for article (PubMed ID: 25973222)
1. External validation of a prediction model for pathologic N2 among patients with a negative mediastinum by positron emission tomography.
Farjah F; Backhus LM; Varghese TK; Manning JP; Cheng AM; Mulligan MS; Wood DE
J Thorac Dis; 2015 Apr; 7(4):576-84. PubMed ID: 25973222
[TBL] [Abstract][Full Text] [Related]
2. A prediction model for pathologic N2 disease in lung cancer patients with a negative mediastinum by positron emission tomography.
Farjah F; Lou F; Sima C; Rusch VW; Rizk NP
J Thorac Oncol; 2013 Sep; 8(9):1170-80. PubMed ID: 23945387
[TBL] [Abstract][Full Text] [Related]
3. A Prediction Model to Optimize Invasive Mediastinal Staging Procedures for Non-small Cell Lung Cancer in Patients With a Radiologically Normal Mediastinum: The Quebec Prediction Model.
Guinde J; Bourdages-Pageau E; Collin-Castonguay MM; Laflamme L; Lévesque-Laplante A; Marcoux S; Roy P; Ugalde PA; Lacasse Y; Fortin M
Chest; 2021 Dec; 160(6):2283-2292. PubMed ID: 34119514
[TBL] [Abstract][Full Text] [Related]
4. Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computer tomography scan.
Gómez-Caro A; Garcia S; Reguart N; Arguis P; Sanchez M; Gimferrer JM; Marrades R; Lomeña F
Eur J Cardiothorac Surg; 2010 May; 37(5):1168-74. PubMed ID: 20116273
[TBL] [Abstract][Full Text] [Related]
5. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
6. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer.
Kamigaichi A; Tsutani Y; Mimae T; Miyata Y; Shimada Y; Ito H; Nakayama H; Ikeda N; Okada M
Clin Lung Cancer; 2021 Mar; 22(2):120-126.e3. PubMed ID: 33485802
[TBL] [Abstract][Full Text] [Related]
7. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
[TBL] [Abstract][Full Text] [Related]
8. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.
Trister AD; Pryma DA; Xanthopoulos E; Kucharczuk J; Sterman D; Rengan R
Am J Clin Oncol; 2014 Apr; 37(2):135-9. PubMed ID: 23111361
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography.
Al-Sarraf N; Aziz R; Gately K; Lucey J; Wilson L; McGovern E; Young V
Eur J Cardiothorac Surg; 2008 Jan; 33(1):104-9. PubMed ID: 17977738
[TBL] [Abstract][Full Text] [Related]
13. FDG-PET parameters predicting mediastinal malignancy in lung cancer.
Serra Fortuny M; Gallego M; Berna L; Montón C; Vigil L; Masdeu MJ; Fernández-Villar A; Botana MI; Cordovilla R; García-Luján R; Cases E; Monsó E
BMC Pulm Med; 2016 Dec; 16(1):177. PubMed ID: 27931198
[TBL] [Abstract][Full Text] [Related]
14. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
15. [Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2)].
Sánchez Sánchez R; Rodríguez Fernández A; Gómez Río M; Alkurdi Martínez A; Castellón Rubio VE; Ramos Font C; Sánchez-Palencia Ramos A; Delgado Pérez JR; Llamas Elvira JM
Rev Esp Med Nucl; 2011; 30(4):211-6. PubMed ID: 21514978
[TBL] [Abstract][Full Text] [Related]
16. Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
Decaluwé H; Moons J; Fieuws S; De Wever W; Deroose C; Stanzi A; Depypere L; Nackaerts K; Coolen J; Lambrecht M; Verbeken E; De Ruysscher D; Vansteenkiste J; Van Raemdonck D; De Leyn P; Dooms C;
Eur J Cardiothorac Surg; 2018 Jul; 54(1):134-140. PubMed ID: 29447330
[TBL] [Abstract][Full Text] [Related]
17. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
Mallorie A; Goldring J; Patel A; Lim E; Wagner T
Nucl Med Commun; 2017 Aug; 38(8):715-719. PubMed ID: 28658052
[TBL] [Abstract][Full Text] [Related]
18. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
[TBL] [Abstract][Full Text] [Related]
19. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
20. Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
Lin JT; Yang XN; Zhong WZ; Liao RQ; Dong S; Nie Q; Weng SX; Fang XJ; Zheng JY; Wu YL
Eur J Cardiothorac Surg; 2016 Nov; 50(5):914-919. PubMed ID: 27113090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
